OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALPS55

Alps Group Inc

Healthcare Facilities & ServicesVerified

Alps Group Inc has a basic and diluted share count of 172,435,326 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics for Alps Group Inc are not available in the valuation snapshot, making it difficult to compare its performance against industry_config preferred metrics or cohort medians. Without these metrics, an assessment of its operational efficiency and capital returns is not possible at this time. Segment and geographic exposure data for Alps Group Inc are not disclosed in the available financial reports, which limits the ability to assess revenue concentration or geographic diversification. This lack of detail prevents a comprehensive evaluation of the company's exposure to regional economic conditions or market-specific risks. Growth trajectory data for Alps Group Inc is not available in the outlook section, and historical revenue data is insufficient to determine a clear growth pattern. Without numeric deltas or revenue history, it is not possible to project the company's future performance or assess its growth potential. Risk factors for Alps Group Inc include the inability to assess liquidity risk due to missing balance-sheet data and the absence of going-concern language in source documents. The company's dilution potential is currently low, as there is no evidence of share-based compensation or convertible instruments affecting the share count. Recent events and filings for Alps Group Inc do not provide additional insights into the company's operations or strategic direction. The lack of detailed disclosures in recent filings or transcripts limits the ability to identify material developments or management commentary that could impact the company's future performance.

30-day price · ALPS-0.23 (-23.0%)
Low$0.64High$1.00Close$0.77As of28 May, 00:00 UTC
Profile
CompanyAlps Group Inc
TickerALPS.O
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Alps Group Inc operates in the healthcare sector, focusing on pharmaceuticals and healthcare facilities and services.

Classification. Alps Group Inc is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Healthcare Facilities & Services industry with a confidence level of 0.92.

Alps Group Inc has a basic and diluted share count of 172,435,326 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics for Alps Group Inc are not available in the valuation snapshot, making it difficult to compare its performance against industry_config preferred metrics or cohort medians. Without these metrics, an assessment of its operational efficiency and capital returns is not possible at this time. Segment and geographic exposure data for Alps Group Inc are not disclosed in the available financial reports, which limits the ability to assess revenue concentration or geographic diversification. This lack of detail prevents a comprehensive evaluation of the company's exposure to regional economic conditions or market-specific risks. Growth trajectory data for Alps Group Inc is not available in the outlook section, and historical revenue data is insufficient to determine a clear growth pattern. Without numeric deltas or revenue history, it is not possible to project the company's future performance or assess its growth potential. Risk factors for Alps Group Inc include the inability to assess liquidity risk due to missing balance-sheet data and the absence of going-concern language in source documents. The company's dilution potential is currently low, as there is no evidence of share-based compensation or convertible instruments affecting the share count. Recent events and filings for Alps Group Inc do not provide additional insights into the company's operations or strategic direction. The lack of detailed disclosures in recent filings or transcripts limits the ability to identify material developments or management commentary that could impact the company's future performance.
Key takeaways
  • Alps Group Inc operates in the healthcare sector with a focus on pharmaceuticals and healthcare facilities and services.
  • The company has no immediate dilution pressure, as basic and diluted share counts are equal.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • Profitability and return metrics are not available, making it difficult to compare performance against industry benchmarks.
  • Segment and geographic exposure data are not disclosed, limiting the ability to assess revenue concentration or geographic diversification.
  • Growth trajectory and historical revenue data are insufficient to determine a clear growth pattern.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Pharmaceuticals · cohort 779 companies
MetricALPSActivity
Op margin7.7% medp25 -2.4% · p75 15.5%
Net margin5.9% medp25 -3.8% · p75 12.8%
Gross margin45.5% medp25 31.1% · p75 62.9%
R&D / revenue529.2% medp25 465.2% · p75 593.2%
CapEx / revenue-7.0% medp25 -14.9% · p75 -3.2%
Debt / equity25.0% medp25 3.8% · p75 63.3%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 02:52 UTC#a763adfb
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 08:15 UTCJob: c7d37238